Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity.
Minnai F, Shkodra M, Noci S, Esposito M, Brunelli C, Pigni A, Zecca E, Skorpen F, Klepstad P, Kaasa S, Corli O, Pallotti MC, Maltoni MC, Caraceni AT, Colombo F. Minnai F, et al. Among authors: zecca e. Eur J Pain. 2025 Jan;29(1):e4764. doi: 10.1002/ejp.4764. Eur J Pain. 2025. PMID: 39629963 Free PMC article.
The validity of average 8-h pain intensity assessment in cancer patients.
Caraceni A, Zecca E, Martini C, Brunelli C, Pigni A, Gorni G, Galbiati A, Ibazeta M, Hjermstad M, Kaasa S. Caraceni A, et al. Among authors: zecca e. Eur J Pain. 2010 Apr;14(4):441-5. doi: 10.1016/j.ejpain.2009.07.004. Epub 2009 Aug 18. Eur J Pain. 2010. PMID: 19692275
Effects of transdermal buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain Outcome Research (CPOR) Study Group.
Apolone G, Corli O, Negri E, Mangano S, Montanari M, Greco MT; Cancer Pain Outcome Research Study Group (CPOR SG) Investigators; Apolone G, Bertetto O, Caraceni A, Corli O, De Conno F, Labianca R, Maltoni M, Nicora Maria F, Torri V, Zucco F. Apolone G, et al. Clin J Pain. 2009 Oct;25(8):671-82. doi: 10.1097/AJP.0b013e3181a38f9d. Clin J Pain. 2009. PMID: 19920716 Clinical Trial.
Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial.
Zecca E, Brunelli C, Bracchi P, Biancofiore G, De Sangro C, Bortolussi R, Montanari L, Maltoni M, Moro C, Colonna U, Finco G, Roy MT, Ferrari V, Alabiso O, Rosti G, Kaasa S, Caraceni A. Zecca E, et al. J Pain Symptom Manage. 2016 Dec;52(6):783-794.e6. doi: 10.1016/j.jpainsymman.2016.05.030. Epub 2016 Oct 11. J Pain Symptom Manage. 2016. PMID: 27742577 Free article. Clinical Trial.
Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial.
Ricchini F, Caraceni A, Zecca E, Pigni A, Centurioni F, Manzoni A, Kaasa S, Brunelli C. Ricchini F, et al. Among authors: zecca e. J Pain Symptom Manage. 2019 Oct;58(4):587-595. doi: 10.1016/j.jpainsymman.2019.06.016. Epub 2019 Jun 21. J Pain Symptom Manage. 2019. PMID: 31233843 Free article. Clinical Trial.
182 results